These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17637473)

  • 21. Methacholine challenge tests: sample sizes required in crossover trials.
    Neuhäuser M; Jöckel KH
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):27-30. PubMed ID: 16425968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenging the two-minute tidal breathing challenge test.
    Lexmond AJ; Hagedoorn P; Frijlink HW; de Boer AH
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):380-6. PubMed ID: 23509936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-Effectiveness Analysis of 3 Methacholine Challenge Tests: Importance of Simplified Protocols.
    Martínez-Cerón E; García A; Casitas R; Galera R; García-Río F
    J Investig Allergol Clin Immunol; 2016; 26(2):121-4. PubMed ID: 27164632
    [No Abstract]   [Full Text] [Related]  

  • 24. Bronchoprovocation methods: direct challenges.
    Cockcroft DW
    Clin Rev Allergy Immunol; 2003 Feb; 24(1):19-26. PubMed ID: 12644716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchial challenge: a small reservoir for the Wright jet nebulizer.
    Madsen F; Nielsen NH; Frølund L; Svendsen UG; Weeke B
    Bull Eur Physiopathol Respir; 1987; 23(1):67-71. PubMed ID: 3593997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Airway responsiveness to methacholine and deep inhalations in subjects with rhinitis without asthma.
    Crimi E; Saporiti R; Bartolini S; Baroffio M; Pellegrino R; Brusasco V
    J Allergy Clin Immunol; 2008 Feb; 121(2):403-7. PubMed ID: 17980415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doses and models in risk assessment analysis for bronchial hyperresponsiveness.
    de Marco R; Bugiani M; Zanolin E; Verlato G; Rijcken B
    J Clin Epidemiol; 1998 Jan; 51(1):19-28. PubMed ID: 9467631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allergen challenge dose-response slope.
    Cockcroft DW; Davis BE
    J Allergy Clin Immunol; 2008 Nov; 122(5):1034-5. PubMed ID: 18823652
    [No Abstract]   [Full Text] [Related]  

  • 29. Dosimeter: what is the dose?
    Hargreave F
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):14. PubMed ID: 15702809
    [No Abstract]   [Full Text] [Related]  

  • 30. PC
    Amirav I; Newhouse MT
    Am J Respir Crit Care Med; 2019 Apr; 199(8):1037-1038. PubMed ID: 30640509
    [No Abstract]   [Full Text] [Related]  

  • 31. Reply to Amirav and Newhouse: PC
    Kaminsky D; Coates A; Culver B; Cockcroft D; Hallstrand T; Haynes J; MacIntyre N; Wanger J
    Am J Respir Crit Care Med; 2019 Apr; 199(8):1038. PubMed ID: 30640508
    [No Abstract]   [Full Text] [Related]  

  • 32. Truncating the dose range for methacholine challenge tests: three occupational studies.
    Agalliu I; Eisen EA; Hauser R; Redlich CA; Stowe MH; Cullen MR; Wegman DH; Christiani DC; Kennedy SM
    J Occup Environ Med; 2003 Aug; 45(8):841-7. PubMed ID: 12915785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calibration of aerosol output from the Mefar dosimeter: implications for epidemiological studies.
    Dennis JH; Avery AJ; Walters EH; Hendrick DJ
    Eur Respir J; 1992 Nov; 5(10):1279-82. PubMed ID: 1486976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation in nebulizer aerosol output and weight output from the Mefar dosimeter: implications for multicentre studies.
    Chinn S; Arossa WA; Jarvis DL; Luczynska CM; Burney PG
    Eur Respir J; 1997 Feb; 10(2):452-6. PubMed ID: 9042648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes of nebulizer output over the years.
    Merkus PJ; van Essen-Zandvliet EE; Parlevliet E; Borsboom G; Sterk PJ; Kerrebijn KF; Quanjer PH
    Eur Respir J; 1992 Apr; 5(4):488-91. PubMed ID: 1563507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of methacholine challenge on alveolar nitric oxide.
    Williamson PA; Clearie K; Vaidyanathan S; Lipworth B
    Thorax; 2009 Jun; 64(6):549-50. PubMed ID: 19478127
    [No Abstract]   [Full Text] [Related]  

  • 37. Recovery time following bronchial challenge.
    Currie GP; Paterson E; Anderson WJ; Lee DK
    Respir Med; 2005 May; 99(5):653. PubMed ID: 15823466
    [No Abstract]   [Full Text] [Related]  

  • 38. Method of nebulizer calibration and methacholine airway responsiveness.
    Davis BE; Todd DC; Cockcroft DW
    J Allergy Clin Immunol; 2004 Dec; 114(6):1474-5. PubMed ID: 15577856
    [No Abstract]   [Full Text] [Related]  

  • 39. [Technical aspects in the Pari provocation test I].
    Mohorn M; Schäfer R
    Pneumologie; 1991 Aug; 45 Suppl 2():651-3. PubMed ID: 1946271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of dosimeter calibration method on nebulizer output.
    Todd DC; Davis BE; Smycniuk AJ; Cockcroft DW
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):45-7. PubMed ID: 15702815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.